Replies to post #355 on Abbott Laboratories (ABT)

[DewDiligence]

ABT +2%/PM on 1Q17 results:

http://finance.yahoo.com/news/abbott-reports-first-quarter-2017-114500041.html

1Q17 non-GAAP EPS was $0.48, beating the Street consensus and ABT’s prior guidance of $0.42-0.44. 1Q17 sales grew 30% YoY including the contribution from STJ, and 3% YoY excluding STJ. (The ABT-STJ merger closed on 1/4/17.)

Non-GAAP EPS guidance for 2017 is unchanged at $2.40-2.50.